NASDAQConsumer DiscretionaryAuto PartsSnapshot 2026-07-23
Reading DORM? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
DORM represents a cautious investment in the Consumer Discretionary sector. The current thesis is mixed, with some positive signals from management but underlying fragility in earnings quality and elevated risk factors.
The market appears to be pricing in a neutral valuation, with expectations that are somewhat elevated compared to peers. This suggests that investors may be anticipating stable performance despite the company's recent challenges.
Fundamentals may remain stable in the near term, as management continues to reaffirm revenue and EPS guidance. However, the fragile earnings quality and elevated risk could lead to volatility if performance does not meet expectations.
The thesis hinges on the performance of sector bellwethers like ORLY, AZO, and HSAI. If these companies continue to perform well, it could provide a favorable backdrop for DORM, but any negative guidance from them could significantly impact DORM's outlook.
Over the next 1 to 3 years, DORM's performance will depend on both sector dynamics and management execution. Not investment advice.
The most important moves since the prior daily snapshot.
Signal changed from 'mixed' to 'mild_favorable'.
Yes, our read has strengthened. The latest earnings beat supports this improvement, indicating that recent financial performance is holding in the top half of its industry. There are no new threats identified that would weaken the thesis.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Hitting or exceeding this EPS would support management's guidance and show earnings strength.
Confirms:Q2 diluted EPS reported at $7.57 or higher.
Disproves:Q2 diluted EPS reported below $7.57.
Why it matters: Tariffs may hurt Dorman's profits and sales growth.
Confirms:Q2 earnings show a big rise in costs due to tariffs.
Disproves:Q2 earnings show costs related to tariffs are stable or decreasing.
Why it matters: Higher tariff costs have affected earnings. Monitoring EPS will show how well Dorman manages these costs.
Confirms:Diluted EPS for Q2 2026 remains within the guided range of $7.57 to $7.97.
Disproves:Diluted EPS for Q2 2026 is below $7.57. This shows tariffs hurt earnings.
Why it matters: Tariffs can change costs and profits. This impacts how much money a company makes.
Confirms:Q2 2026 gross profit margin remains above 36% despite tariff costs.
Disproves:Q2 2026 gross profit margin falls below 36% due to tariffs.
Why it matters: This report will show if Dorman is on track with its 2026 sales and EPS guidance.
Confirms one read:Q2 2026 net sales growth above 7% year-over-year.
Confirms the other:Q2 2026 net sales growth below 7% year-over-year.
Why it matters: A drop below this level would signal weakening demand for Dorman's products.
Confirms:Q1 revenue growth reported below 5% year over year.
Disproves:Q1 revenue growth stays above 5% year over year.
Why it matters: More share repurchases can show that management trusts the company's value and future.
Confirms:Dorman announces a new share repurchase program or increases the current one.
Disproves:If share repurchases go down or stop, it shows management lacks confidence.
Why it matters: Dorman announced a share buyback. Updates on this could indicate confidence in cash flow and capital allocation.
Confirms:More share buybacks are coming. This is on top of the $51 million already done.
Disproves:No further announcements of share repurchases or a halt in the buyback program.
Why it matters: Dorman expects 7% to 9% revenue growth for 2026. Meeting this guidance is key to investor confidence.
Confirms:2026 net sales reported above $2.28 billion.
Disproves:2026 net sales reported below $2.24 billion.
Why it matters: Tariff changes can greatly affect costs and pricing plans.
Confirms one read:Announcement of tariff changes that reduce costs for Dorman.
Confirms the other:They announced new tariffs or raised existing ones.
Why it matters: Completing this will change Dorman's debt and how it manages money.
Confirms:They announced the successful sale of $450 million in senior notes.
Disproves:Not completing the offering or announcing bad terms will be a problem.
Why it matters: Reaffirming EPS guidance shows confidence in earnings. This is important despite recent declines.
Confirms:Management confirms full-year diluted EPS guidance. It is between $7.57 and $7.97.
Disproves:Management revises EPS guidance down from the current range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
